Inspire Investing’s Deciphera Pharmaceuticals, Inc. Common Stock DCPH Stock Holding History

Inspire Investing’s Portfolio DCPH Stock Details DCPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-25,243	Closed	-$397K	–	837
2024 Q1	$397K	Sell	25,243 -1,984	-7%	-$30.5K	0.04%	405
2023 Q4	$439K	Sell	27,227 -305	-1%	-$3.89K	0.05%	372
2023 Q3	$350K	Buy	27,532 +2,583	+10%	+$35.6K	0.04%	375
2023 Q2	$351K	Buy	24,949 +4,981	+25%	+$71.3K	0.04%	394
2023 Q1	$309K	Buy	19,968 +5,479	+38%	+$91.5K	0.04%	396
2022 Q4	$237K	Buy	14,489 +3,301	+30%	+$53.7K	0.03%	386
2022 Q3	$207K	Buy	+11,188	New	+$176K	0.03%	575

Other funds holding DCPH

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Inspire Investing's DCPH Position: Q2 2024 in Review

Inspire Investing sold out of Deciphera Pharmaceuticals, Inc. Common Stock (DCPH) in Q2 2024, closing a stake of 25,243 shares — an estimated $397K sold.

Inspire Investing first reported a position in DCPH in Q3 2022 and held it in 7 quarters. The position peaked at $439K in Q4 2023. 1 fund tracked by Wall St. Rank holds DCPH as of Q2 2024.

Inspire Investing reported no remaining Deciphera Pharmaceuticals, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Inspire Investing sold 25,243 Deciphera Pharmaceuticals, Inc. Common Stock shares in Q2 2024, an estimated $397K.
Inspire Investing first reported a position in Deciphera Pharmaceuticals, Inc. Common Stock in Q3 2022 and held it in 7 quarters.
Inspire Investing's Deciphera Pharmaceuticals, Inc. Common Stock position peaked at $439K in Q4 2023.
1 fund tracked by Wall St. Rank held Deciphera Pharmaceuticals, Inc. Common Stock as of Q2 2024.

Based on Inspire Investing's 13F filing for Q2 2024, filed 12 Aug 2024.